Book a demo

Recalls vs. Reminders: Why RACGP treats them as legally different things

In everyday conversation at a clinic, “recall” and “reminder” tend to get used interchangeably. A patient overdue for a skin check and a patient overdue for a flu shot often end up on the same list, handled the same way, through the same system.

Under the RACGP Standards for General Practices (5th edition), they’re not the same thing, and treating them as if they were is one of the more common gaps practices don’t realise they have until an accreditation visit, or worse, an adverse outcome, brings it into focus.

What the Standards actually say

Criterion GP2.2, which covers follow-up systems, sets out separate indicators for each:

  • GP2.2 B requires that the practice recalls patients who have clinically significant results, this is about following up on results that carry a genuine health risk if missed.
  • GP2.2 D requires that the practice initiates and manages patient reminders, a broader category covering health promotion and preventive care, like screening or vaccination due dates.

The Standards describe the underlying principle plainly: a follow-up system needs to anticipate that different cases require different levels of follow-up depending on clinical significance. A clinically significant result, an abnormal pathology finding, an urgent imaging report, carries a different obligation than a routine reminder that a health check is due.

Why the distinction matters in practice, not just on paper

The practical difference shows up in three places:

  • Urgency and escalation. A missed reminder for a routine screening is a lost opportunity for preventive care. A missed recall on a clinically significant result can be a patient safety issue, which is why GP2.2 also includes a separate requirement (GP2.2 E) for how high-risk, seriously abnormal, or life-threatening results are managed even outside normal opening hours.
  • Documentation expectations. Both need to be tracked reliably, but the standard of evidence expected for a clinically significant recall, that it was actioned, and that the action is recorded in the patient’s file, is generally treated as a higher-stakes requirement than a general reminder system.
  • Legal exposure. Courts have generally treated a missed clinically significant recall as a shared responsibility between clinic and patient, not something a practice can attribute solely to “the patient should have called back.” A system that can’t clearly demonstrate what happened with a clinically significant result is a real risk exposure, separate from the more general expectation that reminders go out reliably.

Where clinics most often blur the line

In smaller practices especially, it’s common for both categories to run through the same generic recall list, sorted by due date rather than by clinical significance. That’s not necessarily non-compliant on its own — the Standards note that a system doesn’t need to be complex to meet the requirement, only reliable. But it does mean that when volume increases, the two categories compete for the same limited follow-up time and attention, with no built-in way to make sure the higher-stakes cases get prioritised first.

What a well-structured system actually needs

Whatever the underlying process looks like, RACGP’s own guidance is consistent: the system needs to be dependable enough that nothing clinically significant slips through, and clear enough that staff can describe how it works if asked during an accreditation visit. In practice, that means being able to separate “this needs to happen or there’s real clinical risk” from “this is due, but a delay isn’t dangerous” — and making sure the first category never waits behind the second simply because both showed up on the same list on the same day.

The infrastructure layer that turns GP clinics from passive waiters into active carers.

Company

About us
Products
Pricing
News
FAQ

Legal

Privacy policy
Terms of service

© 2026 Coda Pty Ltd. All rights reserved.

Made in Australia.